More Globe Newswire

View Older Stories View Newer Stories

Mar 17, 2026 05:39PM Computer Resources of America Earns Place on CRN's Prestigious 2026 Tech Elite 250 List

Mar 17, 2026 05:39PM Computer Resources of America Earns Place on CRN's Prestigious 2026 Tech Elite 250 List

Mar 17, 2026 05:35PM Gran Tierra Energy Inc. Announces Strategic Partnership with Ecopetrol for The Development of Fields in the Middle Magdalena Valley Adjacent to Gran Tierra’s Largest Producing Field

Mar 17, 2026 05:30PM Deep Sea Minerals Corp. Clarifies Disclosure at the Request of the BCSC

Mar 17, 2026 05:30PM Gran Tierra Energy Inc. Provides AGM Update and Announces Board Changes

Mar 17, 2026 05:30PM Coherent Demonstrates InP Technology Innovation With a Broad Range of Products

Mar 17, 2026 05:30PM Marex Group plc provides details for upcoming investor day on March 26, 2026

Mar 17, 2026 05:25PM Durable Launches End-to-End AI Business Platform for Entrepreneurs

Mar 17, 2026 05:15PM Nuvini Announces Extension of Earnout Restructuring Deadline

Mar 17, 2026 05:02PM Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting

Mar 17, 2026 05:02PM AGF Investments Announces Pricing Reductions, Fund Terminations and Fund Merger

Mar 17, 2026 05:01PM ORIC® Pharmaceuticals Announces Preclinical Rinzimetostat (ORIC-944) Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting

Mar 17, 2026 05:01PM Ashland CFO to discuss current market environment at the Gabelli Funds’ 17th Annual Specialty Chemicals Symposium

Mar 17, 2026 05:01PM Ashland CFO to discuss current market environment at the Gabelli Funds’ 17th Annual Specialty Chemicals Symposium

Mar 17, 2026 05:01PM Silexion Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Mar 17, 2026 05:01PM Galapagos Receives Transparency Notification from Bank of America

Mar 17, 2026 05:00PM ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting

Mar 17, 2026 05:00PM Auburn National Bancorporation Authorizes Stock Repurchase Program

Mar 17, 2026 05:00PM Stardust Power Reports Preliminary 2025 Results and Highlights Development Progress at Muskogee Lithium Refinery

Mar 17, 2026 05:00PM ROHM has Introduced Reference Designs for Three-Phase Inverters Featuring New SiC Power Modules

Mar 17, 2026 04:52PM OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital

Mar 17, 2026 04:52PM Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026

Mar 17, 2026 04:52PM What Should Multi-Unit Restaurant Operators Look for When Switching POS Systems? Lavu Publishes 2026 Buyer’s Guide

Mar 17, 2026 04:50PM Star Equity Holdings Reports 2025 Fourth Quarter and Full-Year Results

Mar 17, 2026 04:49PM Caring for the Body, PLLC Launches Physician-Led Re-Think Aging Platform to Advance a New Era of Cognitive Decline Prevention and Longevity Care

Mar 17, 2026 04:45PM Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026

Mar 17, 2026 04:45PM Greystone Housing Impact Investors LP Schedules Fourth Quarter 2025 Earnings Conference Call and Issues Investor Schedule K-1s

Mar 17, 2026 04:45PM Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting

Mar 17, 2026 04:44PM Mr. Rooter Plumbing of North Miami Beach Surpasses 100 Google Reviews with 5-Star Rating

Mar 17, 2026 04:35PM Greystone Provides $46 Million Bridge-to-HUD Loan for Seniors Housing Portfolio in Ohio

Mar 17, 2026 04:35PM Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

Mar 17, 2026 04:35PM Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial

Mar 17, 2026 04:35PM Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival

Mar 17, 2026 04:35PM Adagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA

Mar 17, 2026 04:31PM Sportradar to Participate in the 38th Annual Roth Conference

Mar 17, 2026 04:31PM Prelude Therapeutics Announces Acceptance of Preclinical Abstract for PRT13722, a First-in-Class Oral KAT6A Selective Degrader at the 2026 AACR Annual Meeting

Mar 17, 2026 04:30PM Zentalis Pharmaceuticals to Present Two Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026

Mar 17, 2026 04:30PM SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference

Mar 17, 2026 04:30PM Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days

Mar 17, 2026 04:30PM TransAlta Corporation Announces Conversion Results for Series A and B Preferred Shares

Mar 17, 2026 04:30PM BlossomHill Therapeutics Unveils New Pan-KRAS Inhibitor Programs and Announces Upcoming Presentations at AACR Annual Meeting 2026

Mar 17, 2026 04:30PM Molecular Partners to Hold Three Poster Presentations at AACR 2026

Mar 17, 2026 04:30PM ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 17, 2026 04:30PM Akari Therapeutics Announces ADS Ratio Change

Mar 17, 2026 04:30PM Parsons Announces New Chief Human Resources Officer

Mar 17, 2026 04:30PM UMH PROPERTIES, INC. PUBLISHES ITS 2025 ANNUAL REPORT

Mar 17, 2026 04:30PM Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting

Mar 17, 2026 04:30PM Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum

Mar 17, 2026 04:30PM Enara Bio to Unveil First‑in‑Class DARKFOX‑Targeting Bispecific T Cell Engager ENA101 in Oral Presentation at AACR 2026, Showcasing Breakthrough Potential for Solid Tumor Immunotherapy

Mar 17, 2026 04:30PM Evaxion to present new data at AACR Annual Meeting

View Newer Stories View Older Stories